Latest Articles

Publication Date
UM research team identifies novel targeted therapy for endometrial cancer - University of Macau

UM research team identifies novel targeted therapy for endometrial cancer University of Macau

Published: May 13, 2026, 3:13 a.m.
Elevated CENPA Promotes Endometrial Cancer Progression - Docwire News

Elevated CENPA Promotes Endometrial Cancer Progression Docwire News

Published: May 12, 2026, 11:41 p.m.
Sequencing ADCs in Endometrial Cancer - OncLive

Sequencing ADCs in Endometrial Cancer OncLive

Published: May 12, 2026, 1:04 p.m.
Unmet Needs in Endometrial Cancer - OncLive

Unmet Needs in Endometrial Cancer OncLive

Published: May 12, 2026, 12:59 p.m.
Overcoming Financial and Familiarity Barriers in Endometrial Cancer Management - Pharmacy Times

Overcoming Financial and Familiarity Barriers in Endometrial Cancer Management Pharmacy Times

Published: May 11, 2026, 2:03 p.m.
Clinical Realities of Biomarker Utilization in Advanced Endometrial Cancer - Pharmacy Times

Clinical Realities of Biomarker Utilization in Advanced Endometrial Cancer Pharmacy Times

Published: May 11, 2026, 1:35 p.m.
The power of support: One‑to‑one peer support dramatically improves treatment completion among Black endometrial cancer patients, new trial shows - MSN

The power of support: One‑to‑one peer support dramatically improves treatment completion among Black endometrial cancer patients, new trial shows MSN

Published: May 9, 2026, 10:45 p.m.
Arrivent Announces Ind Clearance For Novel Tetravalent Muc16/Napi2b Targeting Adc Arr-002 With Initial Focus In Ovarian And Endometrial Cancers - TradingView

Arrivent Announces Ind Clearance For Novel Tetravalent Muc16/Napi2b Targeting Adc Arr-002 With Initial Focus In Ovarian And Endometrial Cancers TradingView

Published: May 7, 2026, 12:05 p.m.
Dear Doctor: Endometrial cancer is most common North American gynecological cancer - OregonLive.com

Dear Doctor: Endometrial cancer is most common North American gynecological cancer OregonLive.com

Published: May 6, 2026, 1 p.m.
Four-Year Follow-Up Outcomes in dMMR Endometrial Cancer Presented at SGO 2026 - OncLive

Four-Year Follow-Up Outcomes in dMMR Endometrial Cancer Presented at SGO 2026 OncLive

Published: May 6, 2026, 12:02 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!